Apotex is transforming osteoporosis care across Canada with Health Canada's green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
Apotex is transforming osteoporosis care across Canada with Health Canada's green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
